Pharmaceutical computational chemists leverage advanced computational techniques and molecular modeling tools to accelerate drug discovery and development. By simulating molecular interactions, predicting chemical properties, and designing novel compounds, they help identify promising drug candidates before costly laboratory synthesis and testing. These scientists use methods such as molecular docking, quantum mechanics, and molecular dynamics to understand the behavior of drug molecules and their targets at the atomic level. Their work significantly reduces the time and cost associated with bringing new medications to market, improving efficiency in pharmaceutical research.
Pharmaceutical computational chemists analyze the pharmacokinetics and toxicity profiles of compounds using in silico models, helping to predict how drugs will behave in the human body. They collaborate closely with medicinal chemists, biologists, and pharmacologists to optimize drug candidates and guide experimental efforts. As artificial intelligence and machine learning technologies advance, computational chemists increasingly integrate these tools to enhance predictive accuracy and streamline drug development pipelines. Their expertise is crucial in bridging theoretical chemistry and practical application, driving innovation and improving the success rate of new therapeutic agents. Their contributions are pivotal in shaping the future of personalized medicine and targeted therapies. Furthermore, their work supports the pharmaceutical industry’s efforts to meet evolving regulatory requirements and market demands.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico